Veit Bücklein, Dr Med, on Research Trends in Hematological Malignancy Cell Therapy
January 23rd 2024The postdoctoral researcher at Laboratory for Translational Cancer Immunology, Ludwig-Maximilians-Universität München, discussed research he was excited to see at ASH 2023 and in the field in general.
Sukumar Nagendran, MD, on the Potential of TSHA-102 in Pediatric Patients With Rett Syndrome
January 21st 2024The president and head of R&D at Taysha Gene Therapies discussed his expectation that younger patients my see even better results with the company’s gene therapy than the adult patients treated so far.